Ant Group is the largest shareholder in the China-headquartered mobility services provider, which has chosen the US for its initial public offering.

Alphabet and Merck Group could exit the immunological and inflammatory disease therapy developer in an offering with an $86.3m placeholder target.

Carlyle Group has agreed to pay $435m for the biologics research technology provider, which has raised $86m from investors including Novo.

Internet group Cybridge has purchased the beauty salon booking app operator in a deal of undisclosed size that enabled Adways, Colopl, iStyle, Monex and Vector to exit.

Tencent and CapitalG-backed automation technology provider UiPath has issued approximately $200m of extra shares to close its initial public offering.

3M-backed CNS disorder therapy developer Impel priced its initial public offering in the middle of its range, giving it a $290m market cap.

Max Planck spinout The Captury has been acquired by Dari Motion for an undisclosed amount.

The Amazon-backed residential IoT technology provider will join forces with Nasdaq-listed Fifth Wall Acquisition Corp I at a $2.2bn pro-forma equity valuation.

SoftBank and Hanwha-backed biomanufacturer Zymergen floated at the top of its range in an upsized offering following over $870m in venture funding.

The Medtronic and Johnson & Johnson-backed epilepsy treatment system provider floated at the top of its range and saw its shares rise 47% on their first day.